Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Wider may prevent , impair and renew inflammation

Persistent may let the remain in , impairing and renewing inflammation. No dependence on despite a verified change in would reject this explanation.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Ageing mechanism

Main connectionAltered intercellular communication

Direction

Lens

Puts the cause at the boundaries: the membranes, junctions and barriers that keep compartments apart.Interfaces and barriers

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Goal
Устойчивость восстановления к закреплению повреждённого состояния
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
7 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
9 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
4 / 10Support from research
Poster: Wider contacts impair macrophage engulfment
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Physical property of tissue

    Cell

    The physical arrangement, height and density of molecules on cell surfaces

    Where this hypothesis actsContacts between and tissue cells or their remnants after prior damage

    Hypotheses on this target 1
    Cell surface geometryRemodelling. Hypotheses on this target 11Composition restoration. Hypotheses on this target 0Load normalisation. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Remodelling1
    • Composition restoration
    • Load normalisation
    • Direct measurement

    What is proposed

    Remodelling

    Restore intermembrane spacing that permits complete

    With whatPhysical or surgical intervention

    HowChange the length of an inert molecular linker while keeping ligand density, receptor affinity, cell composition and the current environment constant

    Possible result

    Possible restoration of and prevention of recurrent inflammation without changing nuclear programmes

    From the recordВосстановление подходящего расстояния в фагоцитарном контакте должно разорвать цикл неполной очистки и повторного повреждения

  2. Enzyme

    A cell-surface phosphatase that removes activating

    Where this hypothesis acts with tissue cells and their remnants during

    Hypotheses on this target 1
    CD45Inhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Exclude from the phagocytic contact

    With whatControlled genetic model

    HowShorten intermembrane spacing to sterically exclude ; shorten its extracellular portion as a causal test of that exclusion

    Possible result

    Possible restoration of receptor phosphorylation and

    From the recordПри h>d стерическая цена снижает присутствие фосфатазы в контакте.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαCD45. Hypotheses on this target 1CD45
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and beddingCell surface geometry. Hypotheses on this target 1Cell surface geometry
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Inflammation may return because damaged material remains difficult to remove even after its surroundings recover. The unexpected move is to place the lasting reminder of injury in the physical arrangement of molecules on cell surfaces, rather than solely in persistent activity inside cells. That is a proposal generated by this pipeline, not a measured explanation of recurrent inflammation.

The proposed mechanism, link by link
  1. Earlier injury is proposed to leave a lasting change in the height and density of surface molecules on tissue cells and their remains.
  2. Those altered surfaces would hold the of an approaching farther from the material it needs to remove.
  3. The wider contact would switch from being excluded from the recognition area to remaining inside it.
  4. remaining in the contact would remove activating and weaken the signals needed for .
  5. Incomplete would allow cell material to accumulate again and restart inflammation after surrounding conditions recover.
  6. Restoring a close contact is predicted to exclude , restore removal, and interrupt renewed damage.
A picture for it

A narrow gap beneath a door keeps a bulky object out; raising the door lets that same object pass underneath. Here, widening the gap would admit something that interferes with cleanup.

Where the picture breaks: Cell surfaces are flexible and crowded, and moves within a rather than underneath a door. The picture explains size-dependent access, but it does not establish that injury leaves the gap widened or that changing it prevents inflammation.

  1. Master questionstep 01 of 04

    Several processes involved in aging may reinforce one another, so changing a shared cause could benefit several body systems.

    Rests on: The supplied goal explicitly seeks shared causes whose precise modification might produce benefits across systems.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Recovery should remain stable instead of giving way to a lasting damaged state.

    Rests on: The search for a shared cause is narrowed to the ability to sustain recovery.

    Assumption

    The selection assumes that failure to sustain recovery is a useful shared target for the aging processes in the goal. The supplied goal does not establish that connection.

  3. Gap questionstep 03 of 04

    Inflammation returning after the surroundings recover could reflect lasting changes in tissue cells, in that produce new blood cells, or in reinforcement between those groups. Separate and combined temporary suppression of their persistent activity is proposed to distinguish these possibilities.

    Rests on: Stable recovery makes renewed inflammation a relevant failure to explain, but the preceding stage names no particular cells or persistent activities.

    Leap

    The chain does not supply the bridge from recovery in general to recurrent inflammation specifically, or the basis for selecting these two cellular sources and their interaction as the alternatives to separate.

  4. Hypothesisstep 04 of 04

    Earlier injury is proposed to leave lasting changes in the height and density of molecules on tissue cells and their remains. These changes would widen contact with a , an immune cell that engulfs material, allowing , a surface enzyme that removes involved in signaling, to remain where recognition occurs. Continued removal of activating would weaken , allowing material to accumulate again and inflammation to return.S1

    Rests on: The gap question supplies the problem of inflammation returning after recovery of the surroundings. S1, a 2018 Cell study, supports a central physical link: was impaired when target molecules held attached antibodies more than 10 from a reconstructed target surface. That finding concerns ; it does not establish lasting injury-induced surface changes, removal of natural cell remains, or renewed inflammation.

    Supported by literature

What is carried, and what is not. One screened source, S1 in Cell in 2018, directly supports the central connection between target geometry and in an system; it does not establish the proposed persistent changes after injury or their role in recurrent inflammation. The other screened sources provide background, and none establishes the proposed sequence from prior injury through altered spacing to renewed inflammation and durable recovery.S1

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The selection assumes that failure to sustain recovery is a useful shared target for the aging processes in the goal. The supplied goal does not establish that connection.
  • Gap question. The chain does not supply the bridge from recovery in general to recurrent inflammation specifically, or the basis for selecting these two cellular sources and their interaction as the alternatives to separate. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Changing could be credited with changing contact spacing even if it also changes how readily recognition molecules bind the target. What closes it: The specified controls must hold constant the number of binding molecules per surface area, their binding strength, cell composition, and current surroundings. Actual , presence at the contact, activating on the recognition protein, and must be measured together; alone does not establish the intervening sequence.
  • Successful of engineered, could be mistaken for evidence that the same mechanism clears natural dead-cell material and prevents inflammation from returning. What closes it: The proposed follow-up on natural cell material must establish the persistent surface alteration after injury and connect corrected spacing to completed removal, reduced reaccumulation, and subsequent inflammation after surrounding conditions normalize. Success on engineered targets establishes only the narrower result.
  • Reduced inflammation after shortening the contact could be mistaken for evidence that stores the lasting effect of injury, although the intervention might improve cleanup while another proposed source of inflammation remains active. What closes it: The predicted loss of benefit when is shortened must accompany the spacing result. The persistent activity inside cells must also remain unchanged, as the prediction requires, and the competing explanations must be assessed: , immune detection of the cell's own , or inflammatory fragments of the structural material between cells. The supplied design does not specify tests that exclude all three.

What would make this wrong. The distinctive geometric explanation would be rejected if confirmed changes in , under the specified matched conditions, failed to produce the predicted linked changes in presence, activating , and . Its explanation of recurrent inflammation would also fail if spacing correction restored removal of natural cell material but inflammation still returned under normalized surroundings.

What it would change. If the full proposal held, a physical feature of damaged material could preserve the conditions for renewed inflammation after surrounding signals and tissue stiffness recover. Work seeking a shared intervention against aging would then need to consider whether restoring effective removal can make recovery durable across affected systems. Even that result would not establish a benefit across organs, longer life, or effectiveness in humans; the supplied material gives no defined species, tissue, or follow-up duration for testing the complete sequence.

Sources read · 8

4 literature searches, 5 full texts, 4 abstract-only; 9 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets. · 2018

“Using a reconstituted model of antibody-opsonized target cells, we find that phagocytosis is dramatically impaired for antigens that position antibodies >10 nm from the target surface.”

Does not settle: Источник показывает этот механизм для антитело-опсонизированных реконструированных мишеней, а также инженерных и опухолевых антигенов. Он не устанавливает, что предшествующее повреждение тканей создаёт устойчивую геометрию поверхности, что остатки клеток повторно накапливаются и возвращают воспаление после нормализации сигналов и жёсткости среды, или что восстановление расстояния стабилизирует SPV_6.

S2Background

Syndecan-1 modulates the motility and resolution responses of macrophages. · Arteriosclerosis, thrombosis, and vascular biology · 2015

“These results demonstrate that defective motility in Sdc-1 −/− macrophages promotes a persistent inflammatory state with relevance to the pathogenesis of atherosclerosis.”

Does not settle: It does not establish persistent injury-induced surface geometry on tissue cells or debris, membrane-contact distance, CD45 exclusion, impaired phagocytosis, recurrent inflammation after soluble signals or stiffness normalize, or restoration of contact spacing as an intervention.

S3BackgroundAbstract only

Leucocyte activation markers in clinical practice. · Clinical chemistry and laboratory medicine · 1999

“The response against tissue injury and infection begins with the early activation of molecular and cellular elements of the inflammatory and immune response.”

Does not settle: This abstract does not establish persistent changes in surface geometry, membrane spacing at macrophage contacts, CD45 exclusion or activity, phagocytic clearance, recurrent inflammation after soluble signals normalize, or SPV_6 stabilization.

S4BackgroundAbstract only

Targeting immune-hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026

“The downstream consequences are tightly interlinked, comprising endothelial dysfunction, glycocalyx injury, an unbalanced nitric oxide/endothelin axis, tubuloglomerular feedback disruption, and maladaptive arteriolar remodeling.”

Does not settle: Источник не устанавливает устойчивое изменение геометрии поверхности после повреждения, расстояние в контакте макрофага с клеточным материалом, исключение CD45, эффективность фагоцитоза, повторное накопление материала или возврат воспаления.

S5BackgroundAbstract only

Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy. · The American journal of pathology · 2017

“We show that MCP-1 inhibition restores glomerular endothelial glycocalyx and barrier function and reduces tissue inflammation in the presence of ongoing diabetic injury, suggesting a therapeutic potential for NOX-E36 in diabetic nephropathy.”

Does not settle: Источник оставляет открытыми геометрию фагоцитарного контакта, исключение CD45, поглощение клеточного материала, его накопление и повторное воспаление. Описаны только мыши с диабетической нефропатией.

S6BackgroundAbstract only

Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages. · Journal of immunology (Baltimore, Md. : 1950) · 1996

“Other proteins appear to be regulated by a similar mechanism, because the surface expression of the CD45 isoform B220, of IL-2R, and of CD26 also increased immediately following ingestion of beads by M phi.”

Does not settle: Остаются открытыми геометрия фагоцитарного контакта, исключение CD45, поглощение клеточного материала, устойчивость поверхностных изменений после повреждения и повторное воспаление.

S8Background

Disentangling neuroimmune landscapes across peripheral activation paradigms resolves divergent glial state programs. · Research square · 2026

“In contrast, LPS_Low_Repeated preserved homeostatic genes and enhanced phagocytic markers including Clec7a, Cx3cr1, and Mrc1 , suggesting a reorientation of microglia toward clearance functions.”

Does not settle: Источник не изучает геометрию поверхности, межмембранное расстояние, исключение CD45 из фагоцитарного контакта, неполное поглощение материала или повторное воспаление.

S9Background

In vitro models of microglia: a comparative study. · Scientific reports · 2025

“These findings demonstrate a lack of direct translatability of results between different microglia models and highlight the importance of cross-validating findings.”

Does not settle: Источник не устанавливает влияние геометрии поверхности или межмембранного расстояния на исключение CD45, фагоцитоз, клиренс материала либо возврат воспаления.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Does temporarily silencing memory in tissue cells, blood-forming cells, or both stop inflammation returning after conditions improve?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Что возвращает воспаление после : , память или их взаимное подкрепление, выявляемое раздельным и совместным этих программ?

What this question is asking

The question asks where lasting changes that might restart inflammation are stored. It compares memory within tissue cells, memory in the that produce immune cells, and a cycle in which these two sources keep reactivating each other. The proposed comparison is between temporarily suppressing each memory program separately and suppressing both together after the original harmful conditions have been corrected. The question assumes that memory of physical conditions in tissue cells and inherited memory of altered cellular chemistry have already been demonstrated separately, but that their interaction in an aged organism remains unresolved. Its intended measure of success is recovery toward a common stable condition over weeks, followed by limited remaining loss of function during repeated challenges over months; the supplied material does not specify the challenges or acceptable limits.

What the terms mean
Inflammation
A response involving immune cells and tissue signals to injury or harmful exposure. Here, the outcome is whether that response returns after the original harmful conditions are corrected.
Cellular or inflammatory memory
A lasting change caused by an earlier exposure that alters a cell's later behavior or the behavior of its descendants. It names a class of effects, not conscious memory or one universally defined program.
Tissue cells and autonomous tissue-cell memory
Tissue cells are cells within organs; the question contrasts them with blood-forming precursors. Autonomous memory would mean that a retained change within those tissue cells contributes to later behavior without continued exposure to the original trigger; it does not necessarily mean independence from every outside signal.
Blood-forming stem and precursor cells
Cells that give rise to blood cells, including immune cells. Stem cells can maintain their own population, while precursors are further along the path toward particular blood-cell types; memory in this compartment could affect subsequently produced cells.
Immune cells
Cells involved in defense and responses to damage. The question concerns whether their behavior reflects lasting changes in the cells that produced them.
Mechanical memory
A lasting cellular effect of earlier physical conditions, such as forces or the properties of surrounding material. The pipeline labels this component RL-1, but supplies no definition of that label or direct finding establishing the particular program.
Metabolism and inherited metabolic memory
Metabolism is the set of chemical processes through which cells obtain and use energy and materials. Inherited metabolic memory here means that effects of an earlier metabolic state persist in descendant cells, rather than inheritance between parents and offspring; the pipeline labels it RL-2 without defining that label.
Memory program and reversible suppression
A memory program is shorthand for cellular processes that maintain an exposure's lasting effects. Reversible suppression means temporarily reducing those processes and then allowing the suppressing effect to end; temporary improvement alone would not establish permanent removal of memory.
Mutual reinforcement
A cycle in which changes in one cell group help maintain or restore changes in another, which then acts back on the first. It is one of the possibilities being asked about, not a demonstrated relationship in the supplied evidence.
Environmental correction
Removal or correction of the harmful conditions thought to sustain inflammation. The input does not specify those conditions or a measurement confirming that they have been corrected.
Functional deficit
A remaining reduction in how well a tissue or organism works. The pipeline asks for this loss to remain limited, but supplies neither the function being measured nor its acceptable limit.
Epithelial cells
Cells that cover body surfaces and line internal spaces and organs. S3 identifies them as cells capable of acquiring memory.
Cell-surface signaling protein
A protein at a cell's surface that helps transmit signals into the cell when an activating partner binds. In S2, memory preserves such a protein, supporting continued responsiveness to activating signals.
Neutrophils
A type of immune cell produced from blood-forming cells. S8 measures their increased arrival in the abdominal cavity during a subsequent infection.
Candida albicans
The fungal species used for the earlier exposure and subsequent infection in S8. That result concerns a response to infection, rather than demonstrated spontaneous return of inflammation after environmental correction.
What the question takes for granted
Premise only partly supported
Mechanical memory in tissue cells and inherited metabolic memory in blood-forming precursors have been demonstrated separately, and their interaction in an aged organism has not been established.

Tissue cells are cells within an organ, while blood-forming precursors generate blood cells, including immune cells. The assumption is that the first group can retain effects of earlier physical conditions and the second can pass effects of altered cellular chemistry to its descendants. If established in the relevant setting, these would provide two distinct sources whose contributions to returning inflammation could be compared.

The sources support a narrower premise: lasting changes occur in some tissue-cell settings, and prior exposure of blood-forming cells can affect the responses of their descendants. S2 reports inflammatory memory in pancreatic cancer cells, and S3 reports that cells covering or lining body surfaces acquire memories in living organisms. S8 reports a changed response in immune cells descended from previously exposed blood-forming cells in mice. These findings do not establish the specific mechanical and inherited metabolic programs named in the pipeline statement, their persistence after environmental correction in aged organisms, or their mutual reinforcement. None of the supplied excerpts establishes their interaction; that limitation does not establish that the wider literature lacks such work.S2S3S8

The same question asked without the part nothing read establishes:

  • After harmful conditions are corrected, does temporarily suppressing lasting changes in tissue cells, blood-forming precursors, or both prevent inflammation from returning?
  • What evidence distinguishes tissue-cell memory from blood-forming-precursor memory as a source of returning inflammation after harmful conditions are corrected?
What turns on the answer
  • Tissue-cell memory sustains recurrence Under this outcome, tissue cells would retain the change that restarts inflammation after their surroundings improve. Suppressing that memory would prevent recurrence under the conditions examined, while suppressing memory only in blood-forming precursors would leave the tissue source active.
  • Blood-forming-precursor memory sustains recurrence Under this outcome, blood-forming precursors would continue producing immune cells with an altered response. Suppressing that precursor memory would prevent recurrence under the conditions examined, while suppressing tissue-cell memory alone would leave the continuing supply of altered immune cells.
  • Both memories reinforce each other Under this outcome, activity arising from either cell group would help restore the altered state in the other. Separate temporary suppression would therefore permit recurrence, whereas joint suppression could interrupt the cycle; persistence of that interruption after suppression ends would determine whether recovery lasts.
  • Neither proposed memory explains recurrence If recurrence continued despite effective joint suppression, these two memories would not sufficiently explain its return. The question's proposed choice between them would then leave the actual cause unresolved.
Why it matters

Correcting an ongoing source of inflammation and removing a lasting change caused by that source are different steps. If tissue cells retain a change that restarts inflammation, correcting their surroundings could leave that source of recurrence intact. If blood-forming precursors retain the relevant change, the immune cells they subsequently produce could instead carry the altered response forward. If the two sources reactivate each other, suppressing only one could allow the other to restore the cycle. These are conditional consequences of the question's proposed mechanism: confusing them could lead to mistaking temporary improvement for lasting recovery.

What is already established

RL-1 и RL-2 показаны раздельно; их взаимодействие в старом организме не установлено.

What would have to be true

После устранения стимула траектории сходятся за недели; остаточный остаётся ниже заданных границ при повторных нагрузках месяцами.

What is missing

Неизвестно, какая память восстанавливает патологическое состояние после коррекции среды и достаточно ли устранения одного источника для устойчивого общего эффекта.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Предшествующее повреждение оставляет устойчивое изменение высоты и плотности поверхностных молекул на тканевых клетках и их остатках. При контакте с становится слишком большим для вытеснения из участка распознавания. Она продолжает снимать активирующие , поэтому связанный клеточный материал поглощается плохо. Его повторное накопление возвращает воспаление после . Носитель остаточного состояния здесь представляет собой . Восстановление подходящего расстояния в должно разорвать цикл неполной и повторного повреждения, стабилизируя SPV_6.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

Упаковка, геометрия и : с . Проверяемое приближение: K = c_contact/c_free = exp[-ΔG_steric/(k_B T)], где ΔG_steric = κ[max(0,h-d)]²/2. Здесь K обозначает между контактом и свободной мембраной; c_contact и c_free являются его ; h обозначает внеклеточной части ; d является ; κ обозначает с размерностью энергия/длина²; k_B является ; T обозначает . При h>d снижает присутствие в контакте. служит приближением, параметры которого измеряются независимо. Размерная зависимость экспериментально показана в [исследовании геометрического разделения молекул при ](https://pmc.ncbi.nlm.nih.gov/articles/PMC6067926/).

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковых , , составе клеток и текущей среде изменение только длины меняет присутствие в контакте, и вероятность . Короткий контакт восстанавливает и предотвращает последующее воспаление при сохранении прежних . Укорочение внеклеточной части должно отменять этот эффект, поскольку укороченная снова помещается в контакт. Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable changes under controlled conditions, an intervention expected to abolish the effect, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Модельные мишени с заданной высотой и с изменённой внеклеточной частью позволяют проверять причинность независимо от изменения . Затем требуется подтвердить тот же принцип на естественном клеточном материале: перенос результата с антителозависимого на удаление погибших клеток пока является отдельным предположением.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковых , , составе клеток и текущей среде изменение только длины меняет присутствие в контакте, и вероятность . Короткий контакт восстанавливает и предотвращает последующее воспаление при сохранении прежних . Укорочение внеклеточной части должно отменять этот эффект, поскольку укороченная снова помещается в контакт. Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.

  • What would separate them

    Cell fusion may restart inflammation by combining tissue and immune programs in persistent hybrids predicts: После раздельного и совместного тканевой и кроветворной программ воспаление возвращается преимущественно из клеток, в которых подтверждены обеих . Удаление только этих клеток устраняет рецидив после повторной малой нагрузки; удаление такого же числа соседних этого эффекта не даёт. Обнаружение устойчивого рецидива в с надёжно исключённым и его устранение коррекцией геометрии контакта, или опровергает гипотезу как основное объяснение.

  • What would separate them

    Underedited ribonucleic acid may sustain inflammation through an interferon feedback loop predicts: В очищенных после удаления иммунных клеток возвращению воспаления предшествуют рост конкретных недостаточно отредактированных и активация . Адресное разрушение этих или восстановление предотвращает рецидив; не предотвращает. Для доказательства хранения состояния краткое вмешательство должно давать эффект после своей отмены, а должна воспроизводимо восстанавливать образование причинных . Если нормализовано, но воспаление возвращается и устраняется только коррекцией контакта или , гипотеза отвергается.

  • Rival 03 of 03
    Matrix breakdown may restart inflammation through a peptide-driven feedback loop

    Not yet published.

    What would separate them

    Matrix breakdown may restart inflammation through a peptide-driven feedback loop predicts: ранее повреждённой ткани запускает привлечение в системе из клеток без прежней истории воздействия. Эффект исчезает после избирательного удаления и возвращается при добавлении в измеренной исходной концентрации. Замена клеток при сохранённом допускает рецидив; химическая обработка при сохранённых клетках предотвращает его. Сохранение эффекта после подтверждённого удаления причинных , особенно при зависимости от или геометрии , опровергает гипотезу.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.